Alcaraz, M.
Hernández-Mármol, I.
Puente-Cuadrado, J. M.
Rodríguez-Valiente, M.
Silini, A. R.
Parolini, O.
Nicolás, F. J.
Funding for this research was provided by:
Instituto de Salud Carlos III (PI2101339)
Article History
Received: 7 May 2025
Accepted: 16 September 2025
First Online: 21 October 2025
Declarations
:
: The authors declare no competing interests.
: The study entitled: “Fibroin scaffold functionalized with perinatal cells for the treatment of chronic wounds and diabetic foot ulcers”, was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Hospital Clínico Universitario Virgen de la Arrixaca (IORG0004786) (protocol codes: 2017-1-1-HCUVA, March 2017; 2023-4-1-HCUVA, January 2023). All donors of hAM were anonymized and an informed consent was passed before obtention of donation.
: The authors declare that they have not used AI-generated work in this manuscript.